Please Wait

Applying Filters...

FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

Data Compilation
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

Diatrizoate Meglumine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

6 API Suppliers, 5 USDMF, 3 EU WC, 3 NDC API, 5 Listed Suppliers, $ API Reference Price

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

51 FDF Dossiers, 34 FDA Orange Book, 10 Europe, 1 Canada, 1 South Africa, 5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;ORAL, RECTAL - 66%;10%, SOLUTION;INTRAUTERINE - 52.7%;26.8%, INJECTABLE;INJECTION - 66%;10%

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 4 Kirsch Pharma, 1 Actylis

EXCIPIENTS BY APPLICATIONS

4 Parenteral, 2 Taste Masking, 1 Thickeners and Stabilizers

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 1 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 Regulatory FDF Prices

1 Regulatory FDF Prices

MARKET PLACE

7 APIs, 1 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM, 2 Others

$ Xls

Filters

INJECTABLE;INJECTION - 66%;10%

SOLUTION;INTRAUTERINE - 52.7%;26.8%

SOLUTION;ORAL, RECTAL - 66%;10%

X

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Diatrizoate Meglumine

Diatrizoate Meglumine

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

6 API Suppliers

5 USDMF

3 EU WC

3 NDC API

5 Listed Suppliers

$ API Reference Price

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

51 FDF Dossiers

34 FDA Orange Book

10 Europe

1 Canada

1 South Africa

5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;ORAL, RECTAL - 66%;10%

SOLUTION;INTRAUTERINE - 52.7%;26.8%

INJECTABLE;INJECTION - 66%;10%

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

4 Kirsch Pharma

1 Actylis

EXCIPIENTS BY APPLICATIONS

4 Parenteral

2 Taste Masking

1 Thickeners and Stabilizers

DIGITAL CONTENT

2 Data Compilation #PharmaFlow

1 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 Regulatory FDF Prices

MARKET PLACE

7 APIs

1 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM

2 Others

Filters